PERKINELMER INC (PKI) Stock Fundamental Analysis
USA - NYSE:PKI - US7140461093 - Common Stock
115.24 USD
-1.06 (-0.91%)
115.24 USD
0 (0%)
PKI gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 58 industry peers in the Life Sciences Tools & Services industry. While PKI has a great profitability rating, there are some minor concerns on its financial health. PKI has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
PKI had positive earnings in the past year.
PKI had a positive operating cash flow in the past year.
In the past 5 years PKI has always been profitable.
PKI had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
PKI has a Return On Assets of 5.28%. This is in the better half of the industry: PKI outperforms 76.19% of its industry peers.
PKI's Return On Equity of 10.11% is fine compared to the rest of the industry. PKI outperforms 77.78% of its industry peers.
PKI's Return On Invested Capital of 6.49% is fine compared to the rest of the industry. PKI outperforms 73.02% of its industry peers.
PKI had an Average Return On Invested Capital over the past 3 years of 52.37%. This is significantly above the industry average of 13.51%.
The last Return On Invested Capital (6.49%) for PKI is well below the 3 year average (52.37%), which needs to be investigated, but indicates that PKI had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.28% | ||
| ROE | 10.11% | ||
| ROIC | 6.49% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)52.37%
ROIC(5y)N/A
1.3 Margins
The Profit Margin of PKI (16.32%) is better than 82.54% of its industry peers.
In the last couple of years the Profit Margin of PKI has grown nicely.
With an excellent Operating Margin value of 23.43%, PKI belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.
In the last couple of years the Operating Margin of PKI has grown nicely.
PKI has a Gross Margin of 58.39%. This is in the better half of the industry: PKI outperforms 76.19% of its industry peers.
In the last couple of years the Gross Margin of PKI has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.43% | ||
| PM (TTM) | 16.32% | ||
| GM | 58.39% |
OM growth 3Y19.66%
OM growth 5Y11.6%
PM growth 3Y29.61%
PM growth 5Y5.8%
GM growth 3Y7.46%
GM growth 5Y4.78%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), PKI is creating value.
Compared to 1 year ago, PKI has about the same amount of shares outstanding.
PKI has a better debt/assets ratio than last year.
2.2 Solvency
PKI has an Altman-Z score of 2.51. This is not the best score and indicates that PKI is in the grey zone with still only limited risk for bankruptcy at the moment.
PKI has a Altman-Z score (2.51) which is in line with its industry peers.
PKI has a debt to FCF ratio of 7.40. This is a slightly negative value and a sign of low solvency as PKI would need 7.40 years to pay back of all of its debts.
The Debt to FCF ratio of PKI (7.40) is better than 77.78% of its industry peers.
PKI has a Debt/Equity ratio of 0.53. This is a neutral value indicating PKI is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.53, PKI is doing worse than 68.25% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 7.4 | ||
| Altman-Z | 2.51 |
ROIC/WACC0.65
WACC10.02%
2.3 Liquidity
A Current Ratio of 2.13 indicates that PKI has no problem at all paying its short term obligations.
The Current ratio of PKI (2.13) is worse than 68.25% of its industry peers.
PKI has a Quick Ratio of 1.87. This is a normal value and indicates that PKI is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of PKI (1.87) is worse than 65.08% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.13 | ||
| Quick Ratio | 1.87 |
3. Growth
3.1 Past
PKI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -30.47%.
Measured over the past years, PKI shows a very strong growth in Earnings Per Share. The EPS has been growing by 22.15% on average per year.
The Revenue has decreased by -3.37% in the past year.
The Revenue has been growing slightly by 7.97% on average over the past years.
EPS 1Y (TTM)-30.47%
EPS 3Y24.65%
EPS 5Y22.15%
EPS Q2Q%-33.59%
Revenue 1Y (TTM)-3.37%
Revenue growth 3Y4.72%
Revenue growth 5Y7.97%
Sales Q2Q%-27.89%
3.2 Future
PKI is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.04% yearly.
The Revenue is expected to decrease by -8.60% on average over the next years.
EPS Next Y-34.36%
EPS Next 2Y-12.79%
EPS Next 3Y-4.57%
EPS Next 5Y6.04%
Revenue Next Year-31.32%
Revenue Next 2Y-15.11%
Revenue Next 3Y-8.6%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
PKI is valuated correctly with a Price/Earnings ratio of 14.51.
96.83% of the companies in the same industry are more expensive than PKI, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 26.11, PKI is valued a bit cheaper.
Based on the Price/Forward Earnings ratio of 22.11, the valuation of PKI can be described as rather expensive.
Based on the Price/Forward Earnings ratio, PKI is valued a bit cheaper than 77.78% of the companies in the same industry.
PKI is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.55, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.51 | ||
| Fwd PE | 22.11 |
4.2 Price Multiples
93.65% of the companies in the same industry are more expensive than PKI, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, PKI is valued cheaply inside the industry as 87.30% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 24.52 | ||
| EV/EBITDA | 12.35 |
4.3 Compensation for Growth
The excellent profitability rating of PKI may justify a higher PE ratio.
A cheap valuation may be justified as PKI's earnings are expected to decrease with -4.57% in the coming years.
PEG (NY)N/A
PEG (5Y)0.66
EPS Next 2Y-12.79%
EPS Next 3Y-4.57%
5. Dividend
5.1 Amount
PKI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
115.24
-1.06 (-0.91%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners86.56%
Inst Owner Change0.17%
Ins Owners0.81%
Ins Owner Change0%
Market Cap14.57B
Revenue(TTM)4.57B
Net Income(TTM)746.14M
Analysts73
Price Target159.39 (38.31%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP4.74%
Div Incr Years1
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.02%
Min EPS beat(2)2.33%
Max EPS beat(2)3.7%
EPS beat(4)4
Avg EPS beat(4)8.57%
Min EPS beat(4)2.33%
Max EPS beat(4)14.5%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-29.78%
Min Revenue beat(2)-30.42%
Max Revenue beat(2)-29.14%
Revenue beat(4)2
Avg Revenue beat(4)-0.3%
Min Revenue beat(4)-30.42%
Max Revenue beat(4)52.86%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.68%
PT rev (3m)-2.77%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-20.24%
EPS NY rev (1m)0%
EPS NY rev (3m)-13.69%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-17.56%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-11.39%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.51 | ||
| Fwd PE | 22.11 | ||
| P/S | 3.19 | ||
| P/FCF | 24.52 | ||
| P/OCF | 21.43 | ||
| P/B | 1.97 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.35 |
EPS(TTM)7.94
EY6.89%
EPS(NY)5.21
Fwd EY4.52%
FCF(TTM)4.7
FCFY4.08%
OCF(TTM)5.38
OCFY4.67%
SpS36.16
BVpS58.4
TBVpS-19.59
PEG (NY)N/A
PEG (5Y)0.66
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.28% | ||
| ROE | 10.11% | ||
| ROCE | N/A | ||
| ROIC | 6.49% | ||
| ROICexc | 6.74% | ||
| ROICexgc | 35.96% | ||
| OM | 23.43% | ||
| PM (TTM) | 16.32% | ||
| GM | 58.39% | ||
| FCFM | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)52.37%
ROIC(5y)N/A
ROICexc(3y)8.57%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0.99%
ROICexgc growth 5Y-8%
ROICexc growth 3Y-3.25%
ROICexc growth 5Y0.67%
OM growth 3Y19.66%
OM growth 5Y11.6%
PM growth 3Y29.61%
PM growth 5Y5.8%
GM growth 3Y7.46%
GM growth 5Y4.78%
F-Score7
Asset Turnover0.32
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 7.4 | ||
| Debt/EBITDA | 2.93 | ||
| Cap/Depr | 20.05% | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | 79.63% | ||
| Current Ratio | 2.13 | ||
| Quick Ratio | 1.87 | ||
| Altman-Z | 2.51 |
F-Score7
WACC10.02%
ROIC/WACC0.65
Cap/Depr(3y)26.47%
Cap/Depr(5y)33.81%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)118.43%
Profit Quality(5y)114.16%
High Growth Momentum
Growth
EPS 1Y (TTM)-30.47%
EPS 3Y24.65%
EPS 5Y22.15%
EPS Q2Q%-33.59%
EPS Next Y-34.36%
EPS Next 2Y-12.79%
EPS Next 3Y-4.57%
EPS Next 5Y6.04%
Revenue 1Y (TTM)-3.37%
Revenue growth 3Y4.72%
Revenue growth 5Y7.97%
Sales Q2Q%-27.89%
Revenue Next Year-31.32%
Revenue Next 2Y-15.11%
Revenue Next 3Y-8.6%
Revenue Next 5YN/A
EBIT growth 1Y-24.58%
EBIT growth 3Y25.31%
EBIT growth 5Y20.49%
EBIT Next Year-23.7%
EBIT Next 3Y-3.21%
EBIT Next 5Y3.97%
FCF growth 1Y-54.67%
FCF growth 3Y28.17%
FCF growth 5Y18.96%
OCF growth 1Y-51.81%
OCF growth 3Y23.2%
OCF growth 5Y18.7%
PERKINELMER INC / PKI FAQ
What is the ChartMill fundamental rating of PERKINELMER INC (PKI) stock?
ChartMill assigns a fundamental rating of 4 / 10 to PKI.
What is the valuation status for PKI stock?
ChartMill assigns a valuation rating of 7 / 10 to PERKINELMER INC (PKI). This can be considered as Undervalued.
Can you provide the profitability details for PERKINELMER INC?
PERKINELMER INC (PKI) has a profitability rating of 3 / 10.
Can you provide the financial health for PKI stock?
The financial health rating of PERKINELMER INC (PKI) is 4 / 10.
Is the dividend of PERKINELMER INC sustainable?
The dividend rating of PERKINELMER INC (PKI) is 0 / 10 and the dividend payout ratio is 4.74%.